XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 2 $ 185,364 $ (146,702) $ 38,664
Balance (in shares) at Dec. 31, 2022 20,374,288      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   13   13
Exercise of stock options (in shares) 3,020      
Issuance of common stock under stock incentive plans (in shares) 157,436      
Stock-based compensation expense   1,160   1,160
Net Income (Loss)     761 761
Balance at Mar. 31, 2023 $ 2 186,537 (145,941) 40,598
Balance (in shares) at Mar. 31, 2023 20,534,744      
Balance at Dec. 31, 2022 $ 2 185,364 (146,702) 38,664
Balance (in shares) at Dec. 31, 2022 20,374,288      
Increase (Decrease) in Stockholders' Equity        
Net Income (Loss)       4,646
Balance at Jun. 30, 2023 $ 2 188,126 (142,056) 46,072
Balance (in shares) at Jun. 30, 2023 20,743,422      
Balance at Mar. 31, 2023 $ 2 186,537 (145,941) 40,598
Balance (in shares) at Mar. 31, 2023 20,534,744      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   148   148
Exercise of stock options (in shares) 36,353      
Issuance of common stock under stock incentive plans   181   181
Issuance of common stock under stock incentive plans (in shares) 172,325      
Stock-based compensation expense   1,260   1,260
Net Income (Loss)     3,885 3,885
Balance at Jun. 30, 2023 $ 2 188,126 (142,056) 46,072
Balance (in shares) at Jun. 30, 2023 20,743,422      
Balance at Dec. 31, 2023 $ 2 191,569 (137,650) 53,921
Balance (in shares) at Dec. 31, 2023 21,080,472      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   353   353
Exercise of stock options (in shares) 96,116      
Issuance of common stock under stock incentive plans (in shares) 229,923      
Stock-based compensation expense   1,714   1,714
Net Income (Loss)     (202) (202)
Balance at Mar. 31, 2024 $ 2 193,636 (137,852) 55,786
Balance (in shares) at Mar. 31, 2024 21,406,511      
Balance at Dec. 31, 2023 $ 2 191,569 (137,650) $ 53,921
Balance (in shares) at Dec. 31, 2023 21,080,472      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)       106,741
Net Income (Loss)       $ (2,704)
Balance at Jun. 30, 2024 $ 2 195,774 (140,354) 55,422
Balance (in shares) at Jun. 30, 2024 21,656,683      
Balance at Mar. 31, 2024 $ 2 193,636 (137,852) 55,786
Balance (in shares) at Mar. 31, 2024 21,406,511      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   35   35
Exercise of stock options (in shares) 9,549      
Issuance of common stock under stock incentive plans   241   241
Issuance of common stock under stock incentive plans (in shares) 240,623      
Stock-based compensation expense   1,862   1,862
Net Income (Loss)     (2,502) (2,502)
Balance at Jun. 30, 2024 $ 2 $ 195,774 $ (140,354) $ 55,422
Balance (in shares) at Jun. 30, 2024 21,656,683